menu
    • menu

    Company profile for VectorY

    NEW Drugs in Dev: 2
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide. Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene th...
    VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide. Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a special focus on muscle diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VectorYNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Science Park Matrix Innovation Center 408 1098 XH Amsterdam
    Telephone
    Telephone
    +31(0)202268020
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vectorytx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vectorytx1/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vectory Therapeutics Initiates Vtx-002 Trial In (ALS) Phase 1/2
    Vectory Therapeutics Initiates Vtx-002 Trial In (ALS) Phase 1/2

    09 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260209315923/en/VectorY-Therapeutics-Announces-First-Participant-Dosed-in-Phase-12-PIONEER-ALS-Clinical-Trial-of-VTx-002-in-People-with-Amyotrophic-Lateral-Sclerosis-ALS

    BUSINESSWIRE
    09 Feb 2026
    Share Share
    Vectory Therapeutics Appoints Kevin Pojasek, Ph.D. To Board
    Vectory Therapeutics Appoints Kevin Pojasek, Ph.D. To Board

    05 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-05/vectory-therapeutics-appoints-kevin-pojasek-phd-to-board-of-directors

    PHARMIWEB
    05 Feb 2026
    Share Share
    Vectory Pharma's VTX-002 Granted FDA Fast Track For ALS Antibody
    Vectory Pharma's VTX-002 Granted FDA Fast Track For ALS Antibody

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108064177/en/VectorY-Therapeutics-Receives-FDA-Fast-Track-Designation-for-VTx-002-a-First-in-Class-Vectorized-Antibody-Targeting-Underlying-Disease-Biology-in-ALS

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    Vectory Therapeutics Cleared By FDA For PIONEER-ALS Trial
    Vectory Therapeutics Cleared By FDA For PIONEER-ALS Trial

    03 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251203338299/en/VectorY-Therapeutics-Receives-FDA-Clearance-of-IND-to-Proceed-with-the-PIONEER-ALS-Phase-12-Trial-of-VTx-002-a-First-in-Class-Vectorized-Antibody-Targeting-TDP-43-Pathology-in-ALS

    BUSINESSWIRE
    03 Dec 2025
    Share Share
    VectorY Bets $1.2 B+ on Shape's Brain-Penetrant Capsids
    VectorY Bets $1.2 B+ on Shape's Brain-Penetrant Capsids

    19 Sep 2025

    // BIOSPACE

    https://www.biospace.com/business/vectory-bets-up-to-1-2b-that-shapes-brain-penetrant-capsids-are-a-fit

    BIOSPACE
    19 Sep 2025
    Share Share
    Vector Y Names Jessica Atkinson Chief Business Officer
    Vector Y Names Jessica Atkinson Chief Business Officer

    27 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250527171431/en/VectorY-Therapeutics-Appoints-Jessica-Atkinson-as-Chief-Business-Officer

    BUSINESSWIRE
    27 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search